What is Wedbush's price target for IGMS?

Wedbush's latest stated price target for IGM Biosciences Inc. (IGMS) is $82, from its action on Nov 5, 2021.

What is Wedbush's rating on IGMS?

Wedbush rates IGMS Outperform, a bullish rating, as of Nov 5, 2021.

When did Wedbush last change its view on IGMS?

On Nov 5, 2021, Wedbush upgrades to Outperform from Neutral, price target $82.

Wedbush IGMS price target and rating history

IGM Biosciences Inc. (IGMS) · Health Care

Wedbush rates IGM Biosciences Inc. (IGMS) Outperform with a $82 price target, as of its latest action on Nov 5, 2021. It has published 3 rating actions on IGMS since August 2021, including 2 upgrades and 0 downgrades.

Current rating: Outperform
Price target: $82
Median target, all firms: Too few
Actions on IGMS: 3

Wedbush price target on IGMS

Wedbush price target on IGMS, each point a stated target, August 2021 to November 2021.

Every Wedbush rating on IGMS

Nov 5, 2021
UpgradeWedbush upgrades to Outperform from Neutral, price target $82
Nov 5, 2021
UpgradeWedbush upgrades to Outperform from Neutral
Aug 16, 2021
ReiterateWedbush raises its price target to $82 from $77, keeps Neutral

Questions about Wedbush and IGMS

What is Wedbush's price target for IGMS?: Wedbush's latest stated price target for IGM Biosciences Inc. (IGMS) is $82, from its action on Nov 5, 2021.
What is Wedbush's rating on IGMS?: Wedbush rates IGMS Outperform, a bullish rating, as of Nov 5, 2021.
When did Wedbush last change its view on IGMS?: On Nov 5, 2021, Wedbush upgrades to Outperform from Neutral, price target $82.

More IGMS rating histories

All Wedbush ratings IGMS news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.